Tributary Capital Management, LLC Seagen Inc. Transaction History

Tributary Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$108.81 - $179.33 $467,883 - $771,119	-4,300 Closed	0 $0
Q1 2022 Apr 22, 2022	SELL	$119.61 - $157.85 $873,153 - $1.15 Million	-7,300 Reduced 62.93%	4,300 $619,000
Q4 2021 Jan 06, 2022	SELL	$142.57 - $190.86 $256,626 - $343,548	-1,800 Reduced 13.43%	11,600 $1.79 Million
Q3 2021 Oct 14, 2021	BUY	$142.45 - $169.82 $1.01 Million - $1.21 Million	7,100 Added 112.7%	13,400 $2.28 Million
Q4 2020 Jan 19, 2021	BUY	$164.63 - $211.93 $1.04 Million - $1.34 Million	6,300 New	6,300 $1.1 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Tributary Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Tributary Capital Management, LLC with notifications on news.